SIVmac239 MVA Vaccine with and without a DNA Prime, Similar Prevention of Infection by a Repeated Dose SIVsmE660 Challenge Despite Different Immune Responses

BACKGROUND: Vaccine regimens using different agents for priming and boosting have become popular for enhancing T cell and Ab responses elicited by candidate HIV/AIDS vaccines. Here we use a simian model to evaluate immunogenicity and protective efficacy of a recombinant modified vaccinia Ankara (MVA...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lai, Lilin, Kwa, Sue-Fen, Kozlowski, Pamela A., Montefiori, David C., Nolen, Tracy, Hudgens, Michael G., Johnson, Welkin E., Ferrari, Guido, Hirsch, Vanessa M., Felber, Barbara K., Pavlakis, George N., Earl, Patricia L., Moss, Bernard, Amara, Rama Rao, Robinson, Harriet L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3278564/
https://ncbi.nlm.nih.gov/pubmed/22178526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.12.026
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky